Completed PHASE2 INTERVENTIONAL NCT00477841

Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer

Sponsor: Southeast University, China

Interventions Esophageal stent placement complications of therapy dysphagia scores survival time of therapy

Updated 5 times since 2017 Last updated: Apr 17, 2008 Started: Apr 30, 2004 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Esophageal Cancer, this trial is completed. The trial is conducted by Southeast University, China and has accumulated 5 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Southeast University, China

Data source: Southeast University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China